ENABLING NEUROTECHNOLOGY Paradromics’ Brain-Computer Interface (BCI) platform records brain activity at the highest possible resolution: the individual neuron. Our AI algorithms decode this massive amount of brain-data, enabling the seamless translation of thought into treatments. THE MISSION Data-driven BCI-based technologies for brain health Our technology will help millions with unmet medical needs suffering from paralysis and movement disorders to chronic pain, addiction, depression and other mental health conditions. ABOUT Paradromics was founded in 2015 by a team of engineers and neuroscientists, received early support from both NIH and DARPA, started adding medical device commercialization expertise in 2019, and is currently backed by venture capital.
2015
Paradromics raised undisclosed on March 12, 2025
Investors: NEOM Investment Fund